Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
0 hedge funds and large institutions have $0 invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 7 closing their positions.
100% less funds holding
Funds holding: 7 → 0 (-7)
100% less capital invested
Capital invested by funds: $540K → $0 (-$540K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
ALPS Advisors
Denver,
Colorado
|
-$298K |
| 2 |
Jane Street
New York
|
-$120K |
| 3 |
Renaissance Technologies
New York
|
-$71K |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$36K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7K |
TLC Hedge Fund Activity: Q3 2021 in Review
0 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q3 2021, worth a combined $0 — down 100% from $540K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of TLC and 0 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was ALPS Advisors, exiting entirely with an estimated $298K sold.
- 0 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q3 2021, down from 7 in Q2 2021.
- Funds reported $0 of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q3 2021, down 100% quarter-over-quarter.
- 0 funds opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q3 2021 and 7 closed out, a net change of -7 holders.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q3 2021 was ALPS Advisors, an estimated $298K sold.
Based on aggregated 13F filings for Q3 2021.